3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses (Q54645952)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 5, 2010

Language	Label	Description	Also known as
English	3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses	scientific article published on October 5, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses (English)

1 reference

10.1007/S00894-010-0857-7

https://api.crossref.org/works/10.1007/S00894-010-0857-7

27 July 2024

molecular model

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20922443

27 July 2024

3

object named as

Paola Fossa

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20922443

27 July 2024

author name string

Elena Cichero

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

Laura Buffa

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20922443

27 July 2024

publication date

5 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

number of pages

14

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://hal.archives-ouvertes.fr/hal-00629076/file/PEER_stage2_10.1007%252Fs00894-010-0857-7.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20922443

27 July 2024

http://link.springer.com/content/pdf/10.1007/s00894-010-0857-7.pdf

Portable Document Format

1 reference

10.1007/S00894-010-0857-7

https://api.crossref.org/works/10.1007/S00894-010-0857-7

27 July 2024

http://link.springer.com/article/10.1007/s00894-010-0857-7/fulltext.html

1 reference

10.1007/S00894-010-0857-7

https://api.crossref.org/works/10.1007/S00894-010-0857-7

27 July 2024

http://link.springer.com/content/pdf/10.1007/s00894-010-0857-7

1 reference

10.1007/S00894-010-0857-7

https://api.crossref.org/works/10.1007/S00894-010-0857-7

27 July 2024

Journal of Molecular Modeling

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

17

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

7

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

1537-1550

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

The HIV-1 reverse transcription (RT) process as target for RT inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

New developments in anti-HIV chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Emerging anti-HIV drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

New approaches toward anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1007%2FS00894-010-0857-7

21 January 2018

Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20922443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scoring noncovalent protein-ligand interactions: a continuous differentiable function tuned to compute binding affinities

1 reference

https://pubmed.ncbi.nlm.nih.gov/20922443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in comparative molecular field analysis (CoMFA)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20922443

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress in Clinical and Biological Research

19

291

161

author name string

RD Cramer III

publication date

1989

1 reference

10.1007/S00894-010-0857-7

https://api.crossref.org/works/10.1007/S00894-010-0857-7

27 July 2024

Identifiers

10.1007/S00894-010-0857-7

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20922443

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54645952&oldid=2214154955"